A Massachusetts biotechnology company is laying off 21 employees in Durham amid a broader restructuring and pressure from federal regulators.

Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.

Just how many employees is Sarepta Therapeutics laying off? And why did the FDA reject Ultragenyx's rare disease drug over ...

The restructuring enacted by Sarepta Therapeutics is expected to save up to $400 million in annual costs. Read why I'm ...

After the FDA request, Cambridge, Massachusetts-based Sarepta said in a statement that it will continue to ship the therapy to ambulatory people but maintain a halt it implemented June 15 for ...

Bloomberg has reported that the layoffs are part of a broader effort to streamline operations and improve decision-making efficiency amid economic pressures.

Companies such as Intel, Meta, Microsoft, BlackRock, and UPS are conducting layoffs. Artificial intelligence is reshaping some workforces. See the list of companies letting workers go in 2025.